Concepedia

Federica Orvieto

FO

Statistics

Publications

16

Citations

1.2K

H-Index

13

Active since

2003

Affiliations

IRBM Science Park(Current)

United States Military Academy

Merck & Co., Inc., Rahway, NJ, USA (United States)

Centro di Ricerca per la Patologia Vegetale

University of Rome Tor Vergata

Federica Orvieto is an author at IRBM Science Park specializing in drug discovery, pharmacology, and enzyme inhibition.

Publications per year

2003–2022

16

Publications

16

Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

Vincenzo Summa, Alessia Petrocchi, Fabio Bonelli et al. · Journal of Medicinal Chemistry · 2008 · 634 citations · Full text

, , +17

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene

Mark J. Demma, Claudio Mapelli, Angie Sun et al. · Molecular and Cellular Biology · 2019 · 91 citations · Full text

, , +16

Tetrazole thioacetanilides: Potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant

Ester Muraglia, Olaf Kinzel, Ralph Laufer et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 90 citations · Full text

, , +14

Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV Integrase Inhibitors

Paola Pace, Maria Emilia Di Francesco, Cristina Gardelli et al. · Journal of Medicinal Chemistry · 2007 · 77 citations · Full text

, , +14

Discovery and Synthesis of HIV Integrase Inhibitors:  Development of Potent and Orally Bioavailable N-Methyl Pyrimidones

Cristina Gardelli, Emanuela Nizi, Ester Muraglia et al. · Journal of Medicinal Chemistry · 2007 · 67 citations · Full text

, , +17

1–5 of 16